Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IMMP
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
IMMP
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

IMMP Similar Chart Price Prediction

The price of IMMP is predicted to go up 9.55%, based on the high correlation periods with MBC. The similarity of these two price pattern on the periods is 93.22%.

stocks logo

IMMP

stocks logo

MBC

Up: 9.55%Similarity: 93.22%

IMMP Revenue Forecast

IMMP EPS Forecast

IMMP FAQs

What is bull’s view on IMMP?

IMMP stock is currently trading at $2.05, with a bullish outlook driven by promising Phase I trial results for its lead drug, Eftilagimod alpha, showing a median overall survival of 32.9 months in lung cancer patients. Analysts have raised the price target to $7, reflecting a potential upside of over 240%, supported by strong clinical data and market optimism. Additionally, recent R&D tax incentives enhance its financial position, further bolstering investor confidence.

What is bear's view on IMMP?

IMMP stock currently trades at $2.05, and bears may argue that its valuation is stretched given its speculative nature. Despite promising trial results, the company remains in early-stage development, with no consistent revenue streams to justify significant upside. Additionally, the stock's recent rally could face resistance near $2.50, making it vulnerable to profit-taking.

IMMP VS S&P500

Ask Intellectia about IMMP

IMMP Analyst's Forecast

Joel Beatty

Baird

Buy

2024-11-15

Price Target

$6 → $7

Upside

+246.53%

Baird analyst Joel Beatty raised the firm's price target on Immutep to $7 from $6 and keeps an Outperform rating on the shares. The firm raised its target after the company announced investigator initiated INSIGHT-003 study data today for their lead agent eftilagimod alpha (efti).
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

BANF

BancFirst Corp

$116.73
-0.63%
stocks logo

FIZZ

National Beverage Corp

$40.21
-4.08%
stocks logo

PYCR

Paycor HCM Inc

$22.15
-0.14%
stocks logo

CARG

CarGurus Inc

$31.21
0.42%
stocks logo

JWN

Nordstrom Inc

$24.33
0.04%
stocks logo

BLKB

Blackbaud Inc

$65.9
-1.44%
stocks logo

HGV

Hilton Grand Vacations Inc

$40.51
0.10%
stocks logo

SR

Spire Inc

$76.39
0.99%
stocks logo

SPR

Spirit AeroSystems Holdings Inc

$33.96
-0.03%
stocks logo

ENIC

Enel Chile SA

$3.45
-0.58%